143 related articles for article (PubMed ID: 23366451)
1. Towards a predictive model of electroporation-based therapies using pre-pulse electrical measurements.
Garcia PA; Arena CB; Davalos RV
Annu Int Conf IEEE Eng Med Biol Soc; 2012; 2012():2575-8. PubMed ID: 23366451
[TBL] [Abstract][Full Text] [Related]
2. A numerical investigation of the electric and thermal cell kill distributions in electroporation-based therapies in tissue.
Garcia PA; Davalos RV; Miklavcic D
PLoS One; 2014; 9(8):e103083. PubMed ID: 25115970
[TBL] [Abstract][Full Text] [Related]
3. Modeling of electric field distribution in tissues during electroporation.
Corovic S; Lackovic I; Sustaric P; Sustar T; Rodic T; Miklavcic D
Biomed Eng Online; 2013 Feb; 12():16. PubMed ID: 23433433
[TBL] [Abstract][Full Text] [Related]
4. Mitigation of impedance changes due to electroporation therapy using bursts of high-frequency bipolar pulses.
Bhonsle SP; Arena CB; Sweeney DC; Davalos RV
Biomed Eng Online; 2015; 14 Suppl 3(Suppl 3):S3. PubMed ID: 26355870
[TBL] [Abstract][Full Text] [Related]
5. Intracranial nonthermal irreversible electroporation: in vivo analysis.
Garcia PA; Rossmeisl JH; Neal RE; Ellis TL; Olson JD; Henao-Guerrero N; Robertson J; Davalos RV
J Membr Biol; 2010 Jul; 236(1):127-36. PubMed ID: 20668843
[TBL] [Abstract][Full Text] [Related]
6. Educational application for visualization and analysis of electric field strength in multiple electrode electroporation.
Mahnič-Kalamiza S; Kotnik T; Miklavčič D
BMC Med Educ; 2012 Oct; 12():102. PubMed ID: 23107609
[TBL] [Abstract][Full Text] [Related]
7. Time-Dependent Finite Element Analysis of In Vivo Electrochemotherapy Treatment.
Pintar M; Langus J; Edhemović I; Brecelj E; Kranjc M; Sersa G; Šuštar T; Rodič T; Miklavčič D; Kotnik T; Kos B
Technol Cancer Res Treat; 2018 Jan; 17():1533033818790510. PubMed ID: 30089424
[TBL] [Abstract][Full Text] [Related]
8. Electrical conductivity changes during irreversible electroporation treatment of brain cancer.
Garcia PA; Rossmeisl JH; Davalos RV
Annu Int Conf IEEE Eng Med Biol Soc; 2011; 2011():739-42. PubMed ID: 22254416
[TBL] [Abstract][Full Text] [Related]
9. Electroporation of the Liver: More Than 2 Concurrently Active, Curved Electrodes Allow New Concepts for Irreversible Electroporation and Electrochemotherapy.
Ritter A; Bruners P; Isfort P; Barabasch A; Pfeffer J; Schmitz J; Pedersoli F; Baumann M
Technol Cancer Res Treat; 2018 Jan; 17():1533033818809994. PubMed ID: 30411673
[TBL] [Abstract][Full Text] [Related]
10. The effects of metallic implants on electroporation therapies: feasibility of irreversible electroporation for brachytherapy salvage.
Neal RE; Smith RL; Kavnoudias H; Rosenfeldt F; Ou R; Mclean CA; Davalos RV; Thomson KR
Cardiovasc Intervent Radiol; 2013 Dec; 36(6):1638-1645. PubMed ID: 23942593
[TBL] [Abstract][Full Text] [Related]
11. EView: An electric field visualization web platform for electroporation-based therapies.
Perera-Bel E; Yagüe C; Mercadal B; Ceresa M; Beitel-White N; Davalos RV; Ballester MAG; Ivorra A
Comput Methods Programs Biomed; 2020 Dec; 197():105682. PubMed ID: 32795723
[TBL] [Abstract][Full Text] [Related]
12. In vivo electrical conductivity measurements during and after tumor electroporation: conductivity changes reflect the treatment outcome.
Ivorra A; Al-Sakere B; Rubinsky B; Mir LM
Phys Med Biol; 2009 Oct; 54(19):5949-63. PubMed ID: 19759406
[TBL] [Abstract][Full Text] [Related]
13. Use of conductive gels for electric field homogenization increases the antitumor efficacy of electroporation therapies.
Ivorra A; Al-Sakere B; Rubinsky B; Mir LM
Phys Med Biol; 2008 Nov; 53(22):6605-18. PubMed ID: 18978447
[TBL] [Abstract][Full Text] [Related]
14. Characterization of Conductivity Changes During High-Frequency Irreversible Electroporation for Treatment Planning.
Zhao Y; Bhonsle S; Dong S; Lv Y; Liu H; Safaai-Jazi A; Davalos RV; Yao C
IEEE Trans Biomed Eng; 2018 Aug; 65(8):1810-1819. PubMed ID: 29989932
[TBL] [Abstract][Full Text] [Related]
15. In vivo characterization and numerical simulation of prostate properties for non-thermal irreversible electroporation ablation.
Neal RE; Millar JL; Kavnoudias H; Royce P; Rosenfeldt F; Pham A; Smith R; Davalos RV; Thomson KR
Prostate; 2014 May; 74(5):458-68. PubMed ID: 24442790
[TBL] [Abstract][Full Text] [Related]
16. Electrochemotherapy Using Doxorubicin and Nanosecond Electric Field Pulses: A Pilot in Vivo Study.
Novickij V; Malyško V; Želvys A; Balevičiūtė A; Zinkevičienė A; Novickij J; Girkontaitė I
Molecules; 2020 Oct; 25(20):. PubMed ID: 33050300
[TBL] [Abstract][Full Text] [Related]
17. Synergistic Combination of Electrolysis and Electroporation for Tissue Ablation.
Stehling MK; Guenther E; Mikus P; Klein N; Rubinsky L; Rubinsky B
PLoS One; 2016; 11(2):e0148317. PubMed ID: 26866693
[TBL] [Abstract][Full Text] [Related]
18. Patient-specific treatment planning of electrochemotherapy: procedure design and possible pitfalls.
Pavliha D; Kos B; Zupanič A; Marčan M; Serša G; Miklavčič D
Bioelectrochemistry; 2012 Oct; 87():265-73. PubMed ID: 22341626
[TBL] [Abstract][Full Text] [Related]
19. Oral Mucosa Model for Electrochemotherapy Treatment of Dog Mouth Cancer: Ex Vivo, In Silico, and In Vivo Experiments.
Suzuki DOH; Berkenbrock JA; Frederico MJS; Silva FRMB; Rangel MMM
Artif Organs; 2018 Mar; 42(3):297-304. PubMed ID: 29027689
[TBL] [Abstract][Full Text] [Related]
20. Dynamic finite-element model for efficient modelling of electric currents in electroporated tissue.
Langus J; Kranjc M; Kos B; Šuštar T; Miklavčič D
Sci Rep; 2016 May; 6():26409. PubMed ID: 27211822
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
